FON-2021-0576_INFO.pdf (878.56 kB)
Infographic. Phase I study protocol: NKTR-255 as monotherapy or combined with daratumumab or rituximab in hematologic malignancies
figure
posted on 2021-06-22, 08:36 authored by Nina Shah, Miguel-Angel Perales, Cameron J Turtle, Mitchell S Cairo, Andrew J Cowan, Hayder Saeed, Lihua E Budde, Alan Tan, Zachary Lee, Kazuharu Kai, Mario Q Marcondes, Jonathan Zalevsky, Mary A Tagliaferri, Krina K PatelInfographic summary of the article ‘Phase I study protocol: NKTR-255 as monotherapy or combined with daratumumab or rituximab in hematologic malignancies’
